What is mindfulness and how does MBCT work?

Mindfulness is the practice of paying attention, on purpose, to the present moment, without judging what you find — a trainable cognitive skill, not a spiritual belief system. MBCT (Mindfulness-Based Cognitive Therapy) applies mindfulness practices to the specific problem of depressive relapse: when people have experienced 3 or more depressive episodes, they become sensitised — mild sadness or stress can trigger negative thought patterns ("I'm worthless", "nothing will ever improve") that cascade into full depression. MBCT trains people to recognise these patterns early and respond with awareness rather than automatic reactivity — reducing the likelihood of relapse without needing to eliminate negative thoughts.

Is mindfulness just a placebo or relaxation?

No — this is one of the most common misconceptions. Mindfulness is not relaxation (relaxation is a possible side effect, not the goal). Multiple neuroimaging studies show that MBSR/MBCT practice produces measurable, reproducible changes in brain structure and function: increased grey matter density in the insula, prefrontal cortex and hippocampus (Lazar et al., Harvard); reduced amygdala volume and reactivity; reduced default mode network activity (less rumination); changed connectivity between prefrontal cortex and amygdala (improved emotional regulation). These structural changes have been documented in 8-week MBSR completers compared to controls — they are not explained by relaxation or general wellbeing.

Can mindfulness be harmful?

Yes, for a minority of people. Willoughby Britton's "Cheetah House" research (Brown University) documents that approximately 8% of meditators experience adverse effects — ranging from mild (increased anxiety during initial practice) to severe (depersonalisation, derealisation, dissociation, re-experiencing of trauma). High-risk groups: people with a history of trauma or PTSD; psychosis (current or past); severe depression. Important: these adverse effects are much more likely in intensive meditation retreats (10-day silent retreats) than in structured 8-week MBSR/MBCT groups led by qualified teachers. MBCT was specifically designed as a clinically supervised programme — it is not the same as self-directed app use.

How is mindfulness different from meditation?

Meditation is a broader term for any practice involving focused attention or open awareness. Mindfulness is one specific approach to meditation — characterised by non-judgmental, present-moment awareness. MBSR and MBCT use mindfulness meditation as their core practice, but in a standardised, secular, clinically supervised format with measurable outcomes. Other forms of meditation (transcendental meditation — repeating a mantra; loving-kindness meditation; visualisation; focused concentration) are distinct practices with their own evidence bases (some strong, some weak). Not all "meditation" has the same evidence as MBCT for depression prevention — the specific programme matters.

How does GMJ News cover mindfulness medicine?

GMJ News covers the NICE MBCT approval, Cochrane evidence for recurrent depression, neuroscience basis (fMRI, cortical changes), MBSR vs MBCT distinctions, evidence by condition (Grade A to insufficient), adverse effects and contraindications (trauma), app evidence limitations, and the science of default mode network and pain catastrophising. GMJ position: MBCT is a first-line, evidence-based, NICE-approved treatment for recurrent depression prevention — this is not "alternative" medicine. Other mindfulness applications have promising but less definitive evidence.

Home › Topics › Mindfulness-Based Medicine

Mindfulness-Based Medicine

Q: What does the evidence show?

The evidence is clearest for recurrent depression prevention: NICE England recommends MBCT for people who have had 3 or more depressive episodes, based on multiple RCTs and a major Cochrane review showing MBCT reduces relapse risk by approximately 30-35% compared to usual care. A landmark 2016 JAMA Psychiatry trial showed MBCT was as effective as maintenance antidepressant therapy for preventing relapse. For other conditions: Grade B evidence for anxiety disorders (GAD, social anxiety, panic), chronic pain (especially reducing catastrophising and disability), and cancer distress. Growing evidence for burnout in healthcare workers. Evidence for addiction, insomnia and PTSD is promising but requires more research.

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

Summary Statistics Glossary GMJ news FAQ Documents Organizations Research

Mindfulness-based medicine — encompassing MBSR (Mindfulness-Based Stress Reduction, developed by Jon Kabat-Zinn at the University of Massachusetts in 1979) and MBCT (Mindfulness-Based Cognitive Therapy, developed by Segal, Williams and Teasdale in 2002 — NICE-recommended for prevention of depressive relapse in people with 3 or more previous episodes) — is one of the few complementary approaches with Grade A evidence from randomised controlled trials and neuroscience validation, reducing recurrent depression relapse risk by approximately 30-35% compared to usual care and performing comparably to maintenance antidepressant therapy (WHO/NICE). Mindfulness is not mystical — it is operationally defined as “paying attention, on purpose, to the present moment, non-judgementally” — and neuroscience imaging consistently shows measurable changes in prefrontal cortex activation, amygdala reactivity and default mode network activity, supporting its biological plausibility beyond placebo.

Key messages

MBCT — NICE approved for recurrent depression (Grade A evidence)

NICE England recommends Mindfulness-Based Cognitive Therapy (MBCT) for people who have had 3 or more episodes of depression — as effective as maintenance antidepressant therapy for preventing relapse. This is Grade A evidence (multiple high-quality RCTs) and one of the strongest mainstream endorsements of any mind-body therapy.

MBSR vs MBCT — two distinct programmes

MBSR (Mindfulness-Based Stress Reduction): developed by Jon Kabat-Zinn, University of Massachusetts, 1979. 8-week group programme; secular; mixture of meditation, yoga, body scan, group inquiry; designed for chronic illness and stress. MBCT: 8-week group; adds CBT elements to MBSR; designed specifically to prevent depressive relapse by changing the relationship to negative thoughts rather than changing thought content.

Neuroscience — measurable brain changes

fMRI studies consistently show: increased prefrontal cortex activation (top-down emotional regulation); reduced amygdala reactivity to emotional stimuli; reduced default mode network activity (reduces ruminative mind-wandering); increased insula and anterior cingulate cortex activation (interoceptive awareness). Long-term meditators show increased cortical thickness in regions of attention and interoception (Sara Lazar, Harvard, 2005). These are genuine neurobiological changes.

Evidence by condition — what works

Grade A: MBCT for recurrent depression prevention. Grade B-A: chronic pain (reduces pain catastrophising and disability more than pain intensity); anxiety disorders (GAD, social anxiety, panic — comparable to CBT in some trials); cancer distress and quality of life; healthcare worker burnout. Grade B: ADHD in adults; insomnia (MBSR + CBT-I); PTSD (with trauma-sensitive adaptation). Grade C or insufficient: addiction (some evidence for relapse prevention); eating disorders; psychosis (specialist mindfulness-based programmes exist with caution).

Mindfulness is not mystical — it is attention training

Operational definition (Kabat-Zinn): "Paying attention, on purpose, to the present moment, non-judgementally." This is a trainable cognitive skill, not a spiritual practice — though many people integrate it into Buddhist or other contemplative frameworks. The secular MBSR/MBCT programmes require no religious belief, use scientifically measurable outcome measures, and have been delivered in hospitals, schools, prisons and corporate settings.

Adverse effects — rare but real — especially in trauma

Meditation is not risk-free. Willoughby Britton (Brown University) research: approximately 8% of meditators experience challenging or adverse effects: anxiety or panic exacerbation; depersonalisation/derealisation; re-experiencing trauma; dissociation. Contraindications or caution: active psychosis; severe depression with psychomotor retardation; PTSD without trauma-sensitive modification. Trauma-sensitive mindfulness adaptations (David Treleaven) exist to address these risks.

Key statistics

NICE approved

MBCT for prevention of relapse in recurrent depression (3+ episodes)

NICE/SIGN

30-35%

reduction in depressive relapse risk with MBCT vs usual care

Cochrane 2019

= Antidepressants

MBCT vs maintenance antidepressant for relapse prevention — comparable efficacy

JAMA Psychiatry 2016

~8%

of meditators experience adverse effects (anxiety, depersonalisation, dissociation)

Britton et al.

1979

year Jon Kabat-Zinn developed MBSR at University of Massachusetts

MBSR origin

8 weeks

MBSR and MBCT group programme duration; 2.5 hrs/week + daily home practice

MBSR/MBCT standard

Mindfulness evidence by condition — approximate grade (Cochrane/NICE)

Source: Cochrane/NICE/SIGN. Strongest evidence for recurrent depression prevention; growing evidence for pain and anxiety.

Glossary of key terms

MBSR (Mindfulness-Based Stress Reduction)
Kabat-Zinn/UMMSThe founding secular mindfulness programme, developed by Jon Kabat-Zinn at the University of Massachusetts Medical School Stress Reduction Clinic in 1979. 8-week group programme (10-40 participants); 2.5 hours per weekly class; 6-hour silent retreat; daily home practice (45 minutes). Core practices: body scan meditation; sitting meditation (breath, sounds, sensations, thoughts, choiceless awareness); mindful yoga/movement; informal mindfulness in daily activities. Designed for chronic illness, stress, pain and life challenges. No religious affiliation required.

MBCT (Mindfulness-Based Cognitive Therapy)
Segal/Williams/TeasdaleDeveloped in 2002 by Zindel Segal, Mark Williams and John Teasdale — combining MBSR with cognitive therapy elements specifically to prevent depressive relapse. Key therapeutic mechanism: changing the relationship to negative thoughts (metacognitive awareness — "thoughts are not facts") rather than changing thought content (as in CBT). 8-week group programme; similar structure to MBSR with added cognitive psychoeducation. NICE-recommended for people with 3+ depressive episodes. Also adapted for other conditions: MBCT for cancer (MBCT-Ca); MBCT for children; MBCT for health anxiety.

Default mode network (DMN)
NeuroscienceA brain network (medial prefrontal cortex, posterior cingulate cortex, inferior parietal lobule) active during mind-wandering, self-referential thinking and rumination — the "baseline" state when the mind is not focused on a task. Overactivity of the DMN is associated with depression, rumination and unhappiness. Mindfulness meditation consistently reduces DMN activity and connectivity in neuroimaging studies — supporting a neurobiological basis for reduced rumination with mindfulness practice.

Pain catastrophising
Psychology/PainA psychological amplifier of pain — a cognitive pattern involving magnification of pain sensations, rumination about pain, and helplessness (inability to control or reduce pain). Strongly predicts pain disability, opioid use and poor surgical outcomes — more strongly than actual pain intensity or structural imaging findings. Mindfulness and MBSR reduce pain catastrophising by training non-judgemental awareness of sensations — reducing the "suffering added to pain" even when pain intensity is unchanged.

Trauma-sensitive mindfulness
TreleavenAn adaptation of mindfulness instruction for people with trauma history, developed by David Treleaven. Key modifications: offering choices (rather than directing attention to specific body sensations); window of tolerance (titrating exposure to difficult sensations); grounding techniques as alternatives to eyes-closed body scan; trauma-sensitive language; access to external resources. Important because standard mindfulness instruction can inadvertently trigger trauma responses in people with PTSD, dissociation or a history of abuse.

Mindfulness apps — evidence vs hype
BMJ/ResearchThe global mindfulness app market (Calm, Headspace, Insight Timer) is worth billions — yet evidence for app-delivered mindfulness is substantially weaker than for structured MBSR/MBCT. NHS England commissioned a review (2022): insufficient evidence for clinical benefit from most commercial mindfulness apps. Apps may support established practitioners between classes; they do not substitute for structured teacher-led programmes for clinical conditions. The NICE recommendation is specifically for teacher-delivered MBCT — not self-directed app use.